fda glp-1 warning letters november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns – Partnership for Safe Medicines FDA Alert: Endocrinology Drug Recalls

Description

For patients managing Hashimotos, GLP-1 therapy can offer advantages beyond the scale

GLP-1 agonist Liraglutide prevents MK801-induced schizophrenialike behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice

But a common question persists: Do you have to take these medications forever

Bariatric Surgery: Metabolic and bariatric surgery should be considered for patients with BMI 40 kg/m or 35 kg/m with obesity-related comorbidities

Furthermore, the homeostasis of bone formation and resorption is essential to bone health and might be maintained by GLP-1 in normal bones and restored by GLP-1 in unhealthy bones